XML 66 R19.htm IDEA: XBRL DOCUMENT v3.22.1
Transition Period Comparative Data
9 Months Ended
Dec. 31, 2021
Transition Period Comparative Data [Abstract]  
Transition Period Comparative Data

Note 13 – Transition Period Comparative Data

 

As discussed in Note 1, this Transition Report on Form 10-KT includes financial information for the nine months ended December 31, 2021, and fiscal year ended March 31, 2021. The Statements of Operations and Cash Flows for the nine months ended December 31, 2021 and 2020, are summarized below. All data for the nine months ended December 31, 2020, are derived from the Company’s unaudited condensed financial statements.

 

The Statements of Operations for the nine months ended December 31, 2021 and 2020 is as follows:

 

   Nine months ended
December 31,
 
   2021   2020 
       (Unaudited) 
Operating expenses:        
Research and development  $2,496   $2,635 
Selling, general and administrative   14,367    11,455 
Total operating expenses   16,863    14,090 
           
Loss from operations   (16,863)   (14,090)
           
Other income (expense):          
Other income   
-
    
-
 
Other expense   (55)   (55)
Interest expense   (7)   (2,665)
Loss on exchange of notes payable for common stock and warrants   
-
    (1,521)
Gain (loss) on extinguishment of debt   7    (453)
Gain on forgiveness of PPP loan   431    - 
Change in fair value of warrant liability   
-
    (1,337)
Change in fair value of derivative  liability   
-
    39 
Total other income (expense)   376    (5,992)
           
Net loss  $(16,487)  $(20,082)
           
Net loss per share, basic and diluted:  $(1.13)  $(2.70)
           
Weighted average shares outstanding, basic and diluted:   14,596,019    7,430,701 

 

The Statements of Cash Flows for the nine months ended December 31, 2021 and 2020 is as follows:

 

   Nine months ended
December 31,
 
   2021   2020 
       (Unaudited) 
CASH FLOWS FROM OPERATING ACTIVITIES        
Net loss  $(16,487)  $(20,082)
Adjustments to reconcile net loss to net cash used in operating activities:          
Stock-based compensation   8,458    10,663 
Issuance of common stock to consultants   244    302 
Depreciation and amortization   225    57 
(Gain) loss on extinguishment of debt   (7)   453 
Gain on forgiveness of PPP loan   (431)   - 
Loss on exchange of notes payable for common stock and warrants   
-
    1,521 
Amortization of debt discount   
-
    2,256 
Non-cash expenses for placement agent   
-
    55 
Change in fair value of warrant liability   
-
    1,337 
Change in fair value of derivative liability   
-
    (39)
Changes in operating assets and liabilities:          
Prepaid and other assets   (500)   (189)
Account payable   (126)   120 
Accrued expenses   87    (408)
Accrued interest   
-
    349 
Net cash used in operating activities   (8,537)   (3,605)
CASH FLOWS FROM INVESTING ACTIVITIES          
Purchase of equipment   (552)   (82)
Purchase of patents/R&D license   (264)   (25)
Net cash used in investing activities   (816)   (107)
CASH FLOWS FROM FINANCING ACTIVITIES          
Proceeds from the issuance of common stock, net of fees   
-
    1,599 
Proceeds from the exercise of stock options   186    
-
 
Proceeds from related parties non-interest bearing advance   
-
    25 
Repayment of senior secured promissory note   
-
    (200)
Proceeds from PPP loan   
-
    205 
Repayment of related party non interest bearing advance   
-
    (50)
Repayment of notes payable   
-
    (53)
Proceeds from issuance of senior secured convertible notes and common stock warrants   
-
    2,676 
Common stock repurchased and subsequently canceled   
-
    (450)
Payment of financing costs   
-
    (52)
Net cash provided by financing activities   186    3,700 
Net decrease in cash   (9,167)   (12)
Cash — beginning of year   15,297    48 
Cash — end of year  $6,130   $36 
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:          
Unpaid research and development license included in accounts payable  $
-
   $75 
Beneficial conversion feature in connection with notes payable  $
-
   $619 
Issuance of common stock in connection with conversion of notes  $
-
   $4,494 
Issuance of common stock in connection of notes payable  $
-
   $1,134 
Issuance of common stock in satisfaction of accounts payable  $
-
   $122 
Reclassification of warrant liabilities  $
-
   $2,061 
Issuance of common stock warrants  $
-
   $263 
Unpaid equipment included in accounts payable  $206   $
-
 
SUPPLEMENTAL CASH FLOW INFORMATION          
Cash paid for interest  $6   $60 
Cash paid income taxes  $
-
   $
-